The lack of consensus about optimal treatment of acute myeloid leukaemia (AML) in older adults was highlighted in a panel discussion at ASCO 2019 in Chicago, exploring the theme of more vs less intensive therapy. Setting the scene, Dr Heidi Klepin, professor of haematology and oncology at Wake Forest School of Medicine in North Carolina ...
AML in older adults: more vs less intensive therapy?
By Michael Woodhead
12 Jun 2019